|
Fiscal Period: December
|
2019 |
2020 |
2021 |
2022 |
Capitalization1 |
12 807 | 15 273 | 15 273 | - |
Entreprise Value (EV)1 |
10 433 | 14 028 | 14 360 | 14 231 |
P/E ratio |
-3,76x | -8,96x | -14,0x | -20,5x |
Yield |
- | - | - | - |
Capitalization / Revenue |
3,54x | 6,48x | 4,55x | 3,34x |
EV / Revenue |
2,89x | 5,95x | 4,28x | 3,11x |
EV / EBITDA |
-15,4x | -17,6x | -50,9x | 81,2x |
Price to Book |
4,62x | 6,32x | 9,31x | 10,3x |
Nbr of stocks (in thousands) |
297 696 | 317 523 | 317 523 | - |
Reference price (USD) |
43,0 | 48,1 | 48,1 | 48,1 |
Last update |
02/11/2020 | 01/19/2021 | 01/19/2021 | 01/19/2021 |
1 USD in Million Estimates
|
|
Income Statement Evolution | |
|
|
Annual Income Statement Data |
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
Net sales1 |
2 157 | 3 616 | 2 357 | 3 353 | 4 578 |
EBITDA1 |
-944 | -679 | -798 | -282 | 175 |
Operating profit (EBIT)1 |
- | -752 | -944 | -404 | 25,7 |
Operating Margin |
- | -20,8% | -40,0% | -12,0% | 0,56% |
Pre-Tax Profit (EBT)1 |
- | -2 600 | -1 736 | -1 167 | -842 |
Net income1 |
- | -2 602 | -1 674 | -1 113 | -754 |
Net margin |
- | -72,0% | -71,0% | -33,2% | -16,5% |
EPS2 |
-43,0 | -11,4 | -5,37 | -3,44 | -2,34 |
Dividend per Share2 |
- | - | - | - | - |
Last update |
03/01/2019 | 02/11/2020 | 01/19/2021 | 01/19/2021 | 01/19/2021 |
1 USD in Million 2 USD Estimates
|
|
|
Fiscal Period: December
|
2018 |
2019 |
2020 |
2021 |
2022 |
Net Debt1 |
- | - | - | - | - |
Net Cash position1 |
- | 2 374 | 1 245 | 913 | 1 042 |
Leverage (Debt / EBITDA) |
- | 3,50x | 1,56x | 3,24x | -5,95x |
Free Cash Flow1 |
- | -284 | -1 372 | -604 | 292 |
ROE (Net Profit / Equities) |
- | -45,7% | -60,1% | -71,5% | -38,7% |
Shareholders' equity1 |
- | 5 697 | 2 787 | 1 558 | 1 948 |
ROA (Net Profit / Asset) |
- | -55,1% | -30,5% | -27,8% | -15,3% |
Assets1 |
- | 4 726 | 5 491 | 3 999 | 4 915 |
Book Value Per Share2 |
- | 9,31 | 7,61 | 5,16 | 4,69 |
Cash Flow per Share2 |
-13,3 | -0,46 | -4,21 | -1,52 | 1,11 |
Capex1 |
68,7 | 178 | 99,7 | 154 | 201 |
Capex / Sales |
3,18% | 4,93% | 4,23% | 4,58% | 4,38% |
Last update |
03/01/2019 | 02/11/2020 | 01/11/2021 | 01/11/2021 | 01/11/2021 |
1 USD in Million 2 USD Estimates
|
|
|
| Financial data source © 2021 S&P Global Market Intelligence
|
|
|
Confusion reigns as companies, industries try to navigate U.S. COVID-19 vaccine rollout |
Capitalization (USD) 15 272 857 743 Net sales (USD) 3 615 960 000 Sales / Employee (USD) 755 529 Free-Float capitalization (USD) 11 991 634 954 Avg. Exchange 20 sessions (USD) 268 720 410 Average Daily Capital Traded 1,76%
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Evolution Valeur d'Entreprise / EBITDA
|